Molecular genetic analysis of 14 samples from unrelated individuals with the B 3 phenotype is reported here. Two different molecular changes in the blood group B gene were observed. One case was demonstrated to possess a 247G 3 T mutation, which predicts an Asp83Tyr alteration. The B genes of the other 13 cases were shown to have a G 3 A mutation at the ؉5 nucleotide of intron 3 (intervening sequence 3 [IVS3] ؉ 5G 3 A). Reverse transcription polymerase chain reaction analysis showed that the complete exon 1-exon 7 B transcript was absent, and transcripts that skipped exon 3 were instead present in the RNA sample from the B 3 individual with the IVS3 ؉ 5G 3 A mutation. The result shows that the IVS3 ؉ 5G 3 A mutation destroys the conserved sequence of the splice donor site and leads to the skipping of exon 3 during messenger RNA processing. The 
Introduction
In addition to the common ABO phenotypes, A 1 , A 2 , B, and O, numerous phenotypes with a weak expression of the A or B antigens on the red blood cells (RBCs) have been found. [1] [2] [3] [4] [5] [6] The B 3 phenotype is characterized by mixed-field hemagglutination of RBCs with anti-B and anti-A-anti-B antibodies. Only limited results have been reported on the molecular genetic analysis of 4 B 3 cases so far. 7, 8 The B 3 phenotype was found to be the most common subgroup in Taiwanese. [9] [10] [11] [12] This study presents the molecular genetic analysis of 14 samples from unrelated Taiwanese individuals with the B 3 phenotype.
Study design Sequence analysis of the ABO gene and polymerase chain reaction-restriction fragment length polymorphism analysis
Preparation of the genomic DNAs and the analysis of the 7 exon regions of the ABO genes were as described previously. 13 A polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis was developed to demonstrate the intervening sequence-3 [IVS3] ϩ 5G 3 A mutation in the B gene, as the G 3 A change creates a BsmI site (GAATGC). We combined 100 ng genomic DNA and 15 pmol each forward (CGTACCTGCCTCGAGGCCTTGCAGCTTCAC) and reverse (CAGCAC-CCCGGCCAGCATGGATGCTCCAC) primer in 25 L PCR buffer containing 0.2 mM deoxynucleoside 5Ј-triphosphate and 0.5 U Taq polymerase. The PCR program included 5 minutes at 94°C followed by 30 cycles of 30 seconds at 94°C and 1 minute at 72°C. The PCR products were digested by BsmI enzyme and then analyzed by 3.5% agarose gel electrophoresis.
Analysis of the ABO transcript structure
Total RNAs were prepared from peripheral blood cells. The complementary DNAs (cDNAs) were primed by oligodeoxythymidine primer, and 2 rounds of PCR amplification followed. The first PCR was performed with forward (TTGCGGACGCTGGCCGGAAAACCAAA, spanning the exon 1-2 junction of ABO cDNA) and reverse (TGTCCACGTCCACGCACACCAGG-TAATCCA, locating exon 7) primers. Products from the first PCR were amplified by nested forward (CAAAATGCCACGCACTTCGACCTAT-GATCC, locating exon 2) and reverse (CGCTCGCAGAAGTCACTGATC, locating exon 7) primers. The PCR conditions were similar to those described above, except that the annealing temperatures were 65°C and 60°C in the first and the nested PCR, respectively. The ABO gene of the B 3 individual without the IVS3 ϩ 5G 3 A mutation was analyzed as described above. This B 3 individual was shown to have a B/O 1 genotype, and a nucleotide change of 247G 3 T (translation initiation codon of ABO cDNA as nucleotides 1 to 3) was identified in the B gene. The 247 position locates in the exon 6 region, and the G 3 T mutation predicts an Asp83Tyr amino acid alteration. The nucleotide 247 position of the ABO genes of 30 group B individuals was inspected through PCR amplification and sequencing; none of them possessed a G 3 T mutation.
Results and discussion
Exon 3 is skipped in the transcripts encoded from the B allele with the IVS3 ؉ 5G 3 A mutation
As the IVS3 ϩ 5G 3 A mutation changes the consensus sequence of a splice donor site (GT A / G AGT), [15] [16] [17] [18] the transcript structures encoded from the B allele with the splice site mutation were inspected by reverse transcription PCR (RT-PCR). Two fragments (559 and 424 bp) were obtained from the RNA sample from the group B individual ( Figure 3A, lane B) . Direct sequencing of the products revealed that the larger fragment was composed of the complete B exon 2-exon 7 cDNA structure, while the smaller one had the same structure but without the exon 6 region. RT-PCR of the RNA of the B 3 individual gave 2 smaller products (502 and 367 bp) ( Figure 3A, lane B 3 ). The 502-bp fragment was demonstrated to be the B exon 2-exon 7 structure with exon 3 skipped ( Figure  3B ), and the 367-bp fragment was the same structure without the exon 3 and exon 6 regions.
Although the B 3 individual possesses a normal O 1v allele, the O 1v transcript was not detected in this RT-PCR analysis. This phenomenon is believed to result from a decreased stability of the O allele transcript. 19 The presence of the transcripts without exon 6 For personal use only. on April 6, 2017. by guest www.bloodjournal.org From is believed to result from alternative splicing of the ABO transcripts. 4, 20 The transcript with exon 6 skipped develops a translation stop codon at the exon 5-exon 7 junction, and thus is believed to be unable to produce a product with transferase activity.
The complete exon 1-exon 7 transcript of the B gene was shown to be virtually absent in the RNA of the B 3 individual with the IVS3 ϩ 5G 3 A mutation, and instead, both of the transcripts encoded from the B 3 allele with the splice site mutation skipped exon 3. These results show that the IVS3 ϩ 5G 3 A mutation in the B gene destroys the consensus of the splice donor site and thus leads to the skipping of exon 3 during mRNA splicing processes (Figure 4) . Exon 3 of the ABO gene comprises 57 bp, and the B 3 transcript without exon 3 still retains the reading frame and predicts a protein product that lacks 19 amino acid residues in the N-terminal portion ( Figure 5 ). The deleted segment of the 19 amino acids includes several residues of the predicted transmembrane domain of a normal B transferase. Whether this affects or changes the enzyme characteristic of the transferase is worth further investigation. 
